Summary
Intermittent hypoxia training (IHT) refers to episodic exposure to reduced oxygen in the inspired air
separated by periods of normoxia (IHNT) or hyperoxia (IHHT). Exposure to IHT causes an increase in
the total number of mitochondria, a reduction in the number of structurally modified organelles, and the
appearance of energetically active mitochondria. IHT leads to the reprogramming of mitochondrial
metabolism ensuring adequate ATP production. The use of IHHT greatly inhibits the development of
mitochondrial dysfunction under severe hypoxia, lowers oxidative damage of mitochondria, and
increases the capacity of the endogenous antioxidant system. IHT significantly improves the control of
mitochondrial quality by eliminating damaged and dysfunctional mitochondria through autophagy
(mitophagy) and generating new and healthy mitochondria through the processes of biogenesis and
fusion. Previous studies have shown that IHT influences several underlying aging mechanisms and
increases longevity. IHT diminishes the basal level of mitochondria-dependent oxidative stress that is
supposed to be the key factor modulating life span and health span in aerobes. Furthermore, IHT
influences longevity and speed of development of age-related diseases via several mitochondriaindependent
pathways. Studies have shown that both IHNT and IHHT protocols are safe interventions
to use in humans. In conclusion, intermittent hypoxia training has considerable safe therapeutic potential
to treat multiple clinical conditions and increase mitochondrial function, healthy life, and longevity in
humans

